nodes	percent_of_prediction	percent_of_DWPC	metapath
Raltitrexed—TYMS—Fluorouracil—skin cancer	0.698	1	CbGbCtD
Raltitrexed—FPGS—nipple—skin cancer	0.00761	0.142	CbGeAlD
Raltitrexed—FPGS—Fluoropyrimidine Activity—XRCC3—skin cancer	0.00733	0.307	CbGpPWpGaD
Raltitrexed—FPGS—connective tissue—skin cancer	0.0054	0.1	CbGeAlD
Raltitrexed—FPGS—skin of body—skin cancer	0.00487	0.0906	CbGeAlD
Raltitrexed—FPGS—mammalian vulva—skin cancer	0.00444	0.0827	CbGeAlD
Raltitrexed—TYMS—Sorafenib—Vismodegib—skin cancer	0.00419	0.584	CbGdCrCtD
Raltitrexed—Supraventricular tachycardia—Imiquimod—skin cancer	0.00407	0.0187	CcSEcCtD
Raltitrexed—FPGS—lymphoid tissue—skin cancer	0.00395	0.0734	CbGeAlD
Raltitrexed—FPGS—female reproductive system—skin cancer	0.00381	0.0708	CbGeAlD
Raltitrexed—Influenza-like symptoms—Imiquimod—skin cancer	0.00374	0.0172	CcSEcCtD
Raltitrexed—TYMS—connective tissue—skin cancer	0.00354	0.0658	CbGeAlD
Raltitrexed—Dehydration—Vismodegib—skin cancer	0.00342	0.0157	CcSEcCtD
Raltitrexed—TYMS—skin of body—skin cancer	0.0032	0.0595	CbGeAlD
Raltitrexed—FPGS—head—skin cancer	0.00318	0.0591	CbGeAlD
Raltitrexed—Febrile neutropenia—Bleomycin—skin cancer	0.00315	0.0145	CcSEcCtD
Raltitrexed—TYMS—Paclitaxel—Docetaxel—skin cancer	0.00298	0.416	CbGdCrCtD
Raltitrexed—Febrile neutropenia—Dactinomycin—skin cancer	0.00294	0.0135	CcSEcCtD
Raltitrexed—TYMS—mammalian vulva—skin cancer	0.00292	0.0542	CbGeAlD
Raltitrexed—Weight decreased—Vismodegib—skin cancer	0.00288	0.0132	CcSEcCtD
Raltitrexed—TYMS—Fluoropyrimidine Activity—XRCC3—skin cancer	0.00267	0.112	CbGpPWpGaD
Raltitrexed—Febrile neutropenia—Temozolomide—skin cancer	0.00266	0.0122	CcSEcCtD
Raltitrexed—Sinus tachycardia—Docetaxel—skin cancer	0.00264	0.0122	CcSEcCtD
Raltitrexed—Influenza like illness—Imiquimod—skin cancer	0.00259	0.0119	CcSEcCtD
Raltitrexed—TYMS—lymphoid tissue—skin cancer	0.00259	0.0481	CbGeAlD
Raltitrexed—FPGS—Fluoropyrimidine Activity—ERCC2—skin cancer	0.00258	0.108	CbGpPWpGaD
Raltitrexed—Skin exfoliation—Imiquimod—skin cancer	0.00255	0.0117	CcSEcCtD
Raltitrexed—TYMS—female reproductive system—skin cancer	0.0025	0.0464	CbGeAlD
Raltitrexed—Febrile neutropenia—Fluorouracil—skin cancer	0.00245	0.0113	CcSEcCtD
Raltitrexed—Atrial fibrillation—Vemurafenib—skin cancer	0.0024	0.011	CcSEcCtD
Raltitrexed—Necrosis—Dactinomycin—skin cancer	0.00225	0.0104	CcSEcCtD
Raltitrexed—Alopecia—Vismodegib—skin cancer	0.00225	0.0103	CcSEcCtD
Raltitrexed—Influenza-like symptoms—Temozolomide—skin cancer	0.00224	0.0103	CcSEcCtD
Raltitrexed—FPGS—lymph node—skin cancer	0.00223	0.0414	CbGeAlD
Raltitrexed—Extravasation—Bleomycin—skin cancer	0.00217	0.01	CcSEcCtD
Raltitrexed—Dysgeusia—Vismodegib—skin cancer	0.00217	0.00998	CcSEcCtD
Raltitrexed—TYMS—head—skin cancer	0.00209	0.0388	CbGeAlD
Raltitrexed—Atrial fibrillation—Imiquimod—skin cancer	0.00204	0.00941	CcSEcCtD
Raltitrexed—Extravasation—Dactinomycin—skin cancer	0.00203	0.00933	CcSEcCtD
Raltitrexed—Arthralgia—Vismodegib—skin cancer	0.00189	0.00867	CcSEcCtD
Raltitrexed—Necrosis—Fluorouracil—skin cancer	0.00188	0.00864	CcSEcCtD
Raltitrexed—Skin exfoliation—Bleomycin—skin cancer	0.00181	0.00833	CcSEcCtD
Raltitrexed—Weight decreased—Vemurafenib—skin cancer	0.00178	0.00817	CcSEcCtD
Raltitrexed—Febrile neutropenia—Docetaxel—skin cancer	0.00177	0.00814	CcSEcCtD
Raltitrexed—Extravasation—Fluorouracil—skin cancer	0.00169	0.00777	CcSEcCtD
Raltitrexed—Musculoskeletal discomfort—Vismodegib—skin cancer	0.00165	0.00758	CcSEcCtD
Raltitrexed—Supraventricular tachycardia—Docetaxel—skin cancer	0.00162	0.00747	CcSEcCtD
Raltitrexed—Cellulitis—Fluorouracil—skin cancer	0.00162	0.00746	CcSEcCtD
Raltitrexed—Mouth ulceration—Dactinomycin—skin cancer	0.0016	0.00736	CcSEcCtD
Raltitrexed—Dyspepsia—Vismodegib—skin cancer	0.00159	0.00732	CcSEcCtD
Raltitrexed—Decreased appetite—Vismodegib—skin cancer	0.00157	0.00723	CcSEcCtD
Raltitrexed—Influenza like illness—Temozolomide—skin cancer	0.00155	0.00715	CcSEcCtD
Raltitrexed—Pain—Vismodegib—skin cancer	0.00155	0.00711	CcSEcCtD
Raltitrexed—Constipation—Vismodegib—skin cancer	0.00155	0.00711	CcSEcCtD
Raltitrexed—Sepsis—Dactinomycin—skin cancer	0.00153	0.00706	CcSEcCtD
Raltitrexed—Skin exfoliation—Temozolomide—skin cancer	0.00153	0.00703	CcSEcCtD
Raltitrexed—Gastrointestinal pain—Vismodegib—skin cancer	0.00148	0.0068	CcSEcCtD
Raltitrexed—TYMS—lymph node—skin cancer	0.00146	0.0272	CbGeAlD
Raltitrexed—Conjunctivitis—Imiquimod—skin cancer	0.00145	0.00668	CcSEcCtD
Raltitrexed—Abdominal pain—Vismodegib—skin cancer	0.00143	0.00657	CcSEcCtD
Raltitrexed—Hepatic failure—Dactinomycin—skin cancer	0.00143	0.00657	CcSEcCtD
Raltitrexed—Alopecia—Vemurafenib—skin cancer	0.00139	0.00639	CcSEcCtD
Raltitrexed—Necrosis—Docetaxel—skin cancer	0.00136	0.00624	CcSEcCtD
Raltitrexed—Dysgeusia—Vemurafenib—skin cancer	0.00134	0.00616	CcSEcCtD
Raltitrexed—Asthenia—Vismodegib—skin cancer	0.0013	0.00597	CcSEcCtD
Raltitrexed—Hepatic failure—Temozolomide—skin cancer	0.00129	0.00594	CcSEcCtD
Raltitrexed—Sepsis—Fluorouracil—skin cancer	0.00128	0.00588	CcSEcCtD
Raltitrexed—Pruritus—Vismodegib—skin cancer	0.00128	0.00588	CcSEcCtD
Raltitrexed—Diarrhoea—Vismodegib—skin cancer	0.00124	0.00569	CcSEcCtD
Raltitrexed—Extravasation—Docetaxel—skin cancer	0.00122	0.00561	CcSEcCtD
Raltitrexed—Arrhythmia—Imiquimod—skin cancer	0.0012	0.00551	CcSEcCtD
Raltitrexed—Cough—Vemurafenib—skin cancer	0.00119	0.00549	CcSEcCtD
Raltitrexed—Alopecia—Imiquimod—skin cancer	0.00118	0.00545	CcSEcCtD
Raltitrexed—Arthralgia—Vemurafenib—skin cancer	0.00116	0.00536	CcSEcCtD
Raltitrexed—Vomiting—Vismodegib—skin cancer	0.00115	0.00529	CcSEcCtD
Raltitrexed—Rash—Vismodegib—skin cancer	0.00114	0.00524	CcSEcCtD
Raltitrexed—Dermatitis—Vismodegib—skin cancer	0.00114	0.00524	CcSEcCtD
Raltitrexed—Infection—Vemurafenib—skin cancer	0.00111	0.0051	CcSEcCtD
Raltitrexed—Ill-defined disorder—Imiquimod—skin cancer	0.00108	0.00498	CcSEcCtD
Raltitrexed—Dehydration—Temozolomide—skin cancer	0.00108	0.00497	CcSEcCtD
Raltitrexed—Weight decreased—Bleomycin—skin cancer	0.00108	0.00495	CcSEcCtD
Raltitrexed—Nausea—Vismodegib—skin cancer	0.00107	0.00494	CcSEcCtD
Raltitrexed—Malaise—Imiquimod—skin cancer	0.00105	0.00484	CcSEcCtD
Raltitrexed—Neutropenia—Dactinomycin—skin cancer	0.00104	0.00477	CcSEcCtD
Raltitrexed—Stomatitis—Bleomycin—skin cancer	0.00103	0.00476	CcSEcCtD
Raltitrexed—Influenza like illness—Docetaxel—skin cancer	0.00103	0.00475	CcSEcCtD
Raltitrexed—TYMS—E2F transcription factor network—XRCC1—skin cancer	0.00103	0.0431	CbGpPWpGaD
Raltitrexed—Cough—Imiquimod—skin cancer	0.00102	0.00468	CcSEcCtD
Raltitrexed—Musculoskeletal discomfort—Vemurafenib—skin cancer	0.00102	0.00468	CcSEcCtD
Raltitrexed—Skin exfoliation—Docetaxel—skin cancer	0.00102	0.00467	CcSEcCtD
Raltitrexed—Arthralgia—Imiquimod—skin cancer	0.000993	0.00457	CcSEcCtD
Raltitrexed—Discomfort—Imiquimod—skin cancer	0.000982	0.00452	CcSEcCtD
Raltitrexed—Decreased appetite—Vemurafenib—skin cancer	0.000971	0.00447	CcSEcCtD
Raltitrexed—Stomatitis—Dactinomycin—skin cancer	0.000964	0.00444	CcSEcCtD
Raltitrexed—Constipation—Vemurafenib—skin cancer	0.000955	0.00439	CcSEcCtD
Raltitrexed—Oedema—Imiquimod—skin cancer	0.000952	0.00438	CcSEcCtD
Raltitrexed—Infection—Imiquimod—skin cancer	0.000946	0.00435	CcSEcCtD
Raltitrexed—TYMS—Fluoropyrimidine Activity—ERCC2—skin cancer	0.00094	0.0394	CbGpPWpGaD
Raltitrexed—Neutropenia—Temozolomide—skin cancer	0.000938	0.00432	CcSEcCtD
Raltitrexed—Sepsis—Docetaxel—skin cancer	0.000923	0.00425	CcSEcCtD
Raltitrexed—Hyperhidrosis—Imiquimod—skin cancer	0.000921	0.00424	CcSEcCtD
Raltitrexed—FPGS—Fluoropyrimidine Activity—TP53—skin cancer	0.00092	0.0386	CbGpPWpGaD
Raltitrexed—Weight decreased—Temozolomide—skin cancer	0.000908	0.00418	CcSEcCtD
Raltitrexed—Anorexia—Imiquimod—skin cancer	0.000908	0.00418	CcSEcCtD
Raltitrexed—Body temperature increased—Vemurafenib—skin cancer	0.000883	0.00406	CcSEcCtD
Raltitrexed—Stomatitis—Temozolomide—skin cancer	0.000872	0.00401	CcSEcCtD
Raltitrexed—Musculoskeletal discomfort—Imiquimod—skin cancer	0.000868	0.00399	CcSEcCtD
Raltitrexed—Hepatic failure—Docetaxel—skin cancer	0.000859	0.00395	CcSEcCtD
Raltitrexed—Cardiac failure congestive—Docetaxel—skin cancer	0.000851	0.00392	CcSEcCtD
Raltitrexed—Alopecia—Bleomycin—skin cancer	0.000841	0.00387	CcSEcCtD
Raltitrexed—Dyspepsia—Imiquimod—skin cancer	0.000838	0.00386	CcSEcCtD
Raltitrexed—Decreased appetite—Imiquimod—skin cancer	0.000828	0.00381	CcSEcCtD
Raltitrexed—Atrial fibrillation—Docetaxel—skin cancer	0.000815	0.00375	CcSEcCtD
Raltitrexed—Pain—Imiquimod—skin cancer	0.000814	0.00375	CcSEcCtD
Raltitrexed—Renal impairment—Docetaxel—skin cancer	0.000811	0.00373	CcSEcCtD
Raltitrexed—Stomatitis—Fluorouracil—skin cancer	0.000804	0.0037	CcSEcCtD
Raltitrexed—Conjunctivitis—Fluorouracil—skin cancer	0.000801	0.00369	CcSEcCtD
Raltitrexed—Asthenia—Vemurafenib—skin cancer	0.000801	0.00369	CcSEcCtD
Raltitrexed—Pruritus—Vemurafenib—skin cancer	0.00079	0.00363	CcSEcCtD
Raltitrexed—Alopecia—Dactinomycin—skin cancer	0.000785	0.00361	CcSEcCtD
Raltitrexed—Feeling abnormal—Imiquimod—skin cancer	0.000785	0.00361	CcSEcCtD
Raltitrexed—Gastrointestinal pain—Imiquimod—skin cancer	0.000779	0.00358	CcSEcCtD
Raltitrexed—Ill-defined disorder—Bleomycin—skin cancer	0.000769	0.00354	CcSEcCtD
Raltitrexed—Anaemia—Bleomycin—skin cancer	0.000766	0.00353	CcSEcCtD
Raltitrexed—Diarrhoea—Vemurafenib—skin cancer	0.000764	0.00352	CcSEcCtD
Raltitrexed—Abdominal pain—Imiquimod—skin cancer	0.000753	0.00346	CcSEcCtD
Raltitrexed—Body temperature increased—Imiquimod—skin cancer	0.000753	0.00346	CcSEcCtD
Raltitrexed—Malaise—Bleomycin—skin cancer	0.000748	0.00344	CcSEcCtD
Raltitrexed—Leukopenia—Bleomycin—skin cancer	0.000742	0.00341	CcSEcCtD
Raltitrexed—Cough—Bleomycin—skin cancer	0.000723	0.00333	CcSEcCtD
Raltitrexed—Dehydration—Docetaxel—skin cancer	0.000718	0.0033	CcSEcCtD
Raltitrexed—Ill-defined disorder—Dactinomycin—skin cancer	0.000717	0.0033	CcSEcCtD
Raltitrexed—Anaemia—Dactinomycin—skin cancer	0.000715	0.00329	CcSEcCtD
Raltitrexed—FPGS—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—skin cancer	0.000712	0.0299	CbGpPWpGaD
Raltitrexed—Vomiting—Vemurafenib—skin cancer	0.00071	0.00327	CcSEcCtD
Raltitrexed—Alopecia—Temozolomide—skin cancer	0.00071	0.00327	CcSEcCtD
Raltitrexed—Rash—Vemurafenib—skin cancer	0.000704	0.00324	CcSEcCtD
Raltitrexed—Dermatitis—Vemurafenib—skin cancer	0.000703	0.00324	CcSEcCtD
Raltitrexed—Headache—Vemurafenib—skin cancer	0.0007	0.00322	CcSEcCtD
Raltitrexed—Discomfort—Bleomycin—skin cancer	0.000697	0.00321	CcSEcCtD
Raltitrexed—Malaise—Dactinomycin—skin cancer	0.000697	0.00321	CcSEcCtD
Raltitrexed—Leukopenia—Dactinomycin—skin cancer	0.000692	0.00318	CcSEcCtD
Raltitrexed—Dysgeusia—Temozolomide—skin cancer	0.000685	0.00315	CcSEcCtD
Raltitrexed—Asthenia—Imiquimod—skin cancer	0.000683	0.00314	CcSEcCtD
Raltitrexed—Oedema—Bleomycin—skin cancer	0.000677	0.00311	CcSEcCtD
Raltitrexed—Pruritus—Imiquimod—skin cancer	0.000674	0.0031	CcSEcCtD
Raltitrexed—Infection—Bleomycin—skin cancer	0.000672	0.00309	CcSEcCtD
Raltitrexed—Nausea—Vemurafenib—skin cancer	0.000663	0.00305	CcSEcCtD
Raltitrexed—Thrombocytopenia—Bleomycin—skin cancer	0.000662	0.00305	CcSEcCtD
Raltitrexed—Arrhythmia—Fluorouracil—skin cancer	0.000661	0.00304	CcSEcCtD
Raltitrexed—TYMS—Circadian rythm related genes—NKX2-1—skin cancer	0.00066	0.0277	CbGpPWpGaD
Raltitrexed—Alopecia—Fluorouracil—skin cancer	0.000654	0.00301	CcSEcCtD
Raltitrexed—Diarrhoea—Imiquimod—skin cancer	0.000652	0.003	CcSEcCtD
Raltitrexed—Discomfort—Dactinomycin—skin cancer	0.00065	0.00299	CcSEcCtD
Raltitrexed—Ill-defined disorder—Temozolomide—skin cancer	0.000649	0.00299	CcSEcCtD
Raltitrexed—Anaemia—Temozolomide—skin cancer	0.000646	0.00297	CcSEcCtD
Raltitrexed—Anorexia—Bleomycin—skin cancer	0.000645	0.00297	CcSEcCtD
Raltitrexed—Oedema—Dactinomycin—skin cancer	0.000631	0.0029	CcSEcCtD
Raltitrexed—Malaise—Temozolomide—skin cancer	0.000631	0.0029	CcSEcCtD
Raltitrexed—Infection—Dactinomycin—skin cancer	0.000627	0.00288	CcSEcCtD
Raltitrexed—Leukopenia—Temozolomide—skin cancer	0.000626	0.00288	CcSEcCtD
Raltitrexed—Neutropenia—Docetaxel—skin cancer	0.000624	0.00287	CcSEcCtD
Raltitrexed—Thrombocytopenia—Dactinomycin—skin cancer	0.000618	0.00284	CcSEcCtD
Raltitrexed—Musculoskeletal discomfort—Bleomycin—skin cancer	0.000616	0.00284	CcSEcCtD
Raltitrexed—Cough—Temozolomide—skin cancer	0.00061	0.00281	CcSEcCtD
Raltitrexed—Vomiting—Imiquimod—skin cancer	0.000605	0.00279	CcSEcCtD
Raltitrexed—Weight decreased—Docetaxel—skin cancer	0.000604	0.00278	CcSEcCtD
Raltitrexed—Anorexia—Dactinomycin—skin cancer	0.000601	0.00277	CcSEcCtD
Raltitrexed—Rash—Imiquimod—skin cancer	0.0006	0.00276	CcSEcCtD
Raltitrexed—Dermatitis—Imiquimod—skin cancer	0.0006	0.00276	CcSEcCtD
Raltitrexed—Headache—Imiquimod—skin cancer	0.000597	0.00274	CcSEcCtD
Raltitrexed—Anaemia—Fluorouracil—skin cancer	0.000595	0.00274	CcSEcCtD
Raltitrexed—Arthralgia—Temozolomide—skin cancer	0.000595	0.00274	CcSEcCtD
Raltitrexed—Discomfort—Temozolomide—skin cancer	0.000588	0.00271	CcSEcCtD
Raltitrexed—Decreased appetite—Bleomycin—skin cancer	0.000588	0.00271	CcSEcCtD
Raltitrexed—Renal failure—Docetaxel—skin cancer	0.000585	0.00269	CcSEcCtD
Raltitrexed—Stomatitis—Docetaxel—skin cancer	0.00058	0.00267	CcSEcCtD
Raltitrexed—Pain—Bleomycin—skin cancer	0.000579	0.00266	CcSEcCtD
Raltitrexed—Conjunctivitis—Docetaxel—skin cancer	0.000578	0.00266	CcSEcCtD
Raltitrexed—Leukopenia—Fluorouracil—skin cancer	0.000577	0.00265	CcSEcCtD
Raltitrexed—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.000575	0.00264	CcSEcCtD
Raltitrexed—Oedema—Temozolomide—skin cancer	0.000571	0.00263	CcSEcCtD
Raltitrexed—Infection—Temozolomide—skin cancer	0.000567	0.00261	CcSEcCtD
Raltitrexed—Nausea—Imiquimod—skin cancer	0.000566	0.0026	CcSEcCtD
Raltitrexed—Thrombocytopenia—Temozolomide—skin cancer	0.000559	0.00257	CcSEcCtD
Raltitrexed—Feeling abnormal—Bleomycin—skin cancer	0.000558	0.00256	CcSEcCtD
Raltitrexed—Hyperhidrosis—Temozolomide—skin cancer	0.000552	0.00254	CcSEcCtD
Raltitrexed—Decreased appetite—Dactinomycin—skin cancer	0.000549	0.00252	CcSEcCtD
Raltitrexed—Anorexia—Temozolomide—skin cancer	0.000544	0.0025	CcSEcCtD
Raltitrexed—Discomfort—Fluorouracil—skin cancer	0.000542	0.00249	CcSEcCtD
Raltitrexed—Pain—Dactinomycin—skin cancer	0.00054	0.00248	CcSEcCtD
Raltitrexed—Body temperature increased—Bleomycin—skin cancer	0.000535	0.00246	CcSEcCtD
Raltitrexed—Oedema—Fluorouracil—skin cancer	0.000526	0.00242	CcSEcCtD
Raltitrexed—Infection—Fluorouracil—skin cancer	0.000522	0.0024	CcSEcCtD
Raltitrexed—Feeling abnormal—Dactinomycin—skin cancer	0.00052	0.00239	CcSEcCtD
Raltitrexed—Musculoskeletal discomfort—Temozolomide—skin cancer	0.00052	0.00239	CcSEcCtD
Raltitrexed—Gastrointestinal pain—Dactinomycin—skin cancer	0.000516	0.00237	CcSEcCtD
Raltitrexed—Thrombocytopenia—Fluorouracil—skin cancer	0.000515	0.00237	CcSEcCtD
Raltitrexed—Dyspepsia—Temozolomide—skin cancer	0.000502	0.00231	CcSEcCtD
Raltitrexed—Anorexia—Fluorouracil—skin cancer	0.000501	0.00231	CcSEcCtD
Raltitrexed—Body temperature increased—Dactinomycin—skin cancer	0.000499	0.00229	CcSEcCtD
Raltitrexed—Abdominal pain—Dactinomycin—skin cancer	0.000499	0.00229	CcSEcCtD
Raltitrexed—Decreased appetite—Temozolomide—skin cancer	0.000496	0.00228	CcSEcCtD
Raltitrexed—Constipation—Temozolomide—skin cancer	0.000488	0.00225	CcSEcCtD
Raltitrexed—Pain—Temozolomide—skin cancer	0.000488	0.00225	CcSEcCtD
Raltitrexed—Asthenia—Bleomycin—skin cancer	0.000485	0.00223	CcSEcCtD
Raltitrexed—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.000479	0.0022	CcSEcCtD
Raltitrexed—Pruritus—Bleomycin—skin cancer	0.000479	0.0022	CcSEcCtD
Raltitrexed—Arrhythmia—Docetaxel—skin cancer	0.000477	0.0022	CcSEcCtD
Raltitrexed—Alopecia—Docetaxel—skin cancer	0.000472	0.00217	CcSEcCtD
Raltitrexed—Feeling abnormal—Temozolomide—skin cancer	0.00047	0.00216	CcSEcCtD
Raltitrexed—Gastrointestinal pain—Temozolomide—skin cancer	0.000467	0.00215	CcSEcCtD
Raltitrexed—Dyspepsia—Fluorouracil—skin cancer	0.000463	0.00213	CcSEcCtD
Raltitrexed—Decreased appetite—Fluorouracil—skin cancer	0.000457	0.0021	CcSEcCtD
Raltitrexed—Dysgeusia—Docetaxel—skin cancer	0.000455	0.0021	CcSEcCtD
Raltitrexed—Asthenia—Dactinomycin—skin cancer	0.000453	0.00208	CcSEcCtD
Raltitrexed—Body temperature increased—Temozolomide—skin cancer	0.000451	0.00208	CcSEcCtD
Raltitrexed—Abdominal pain—Temozolomide—skin cancer	0.000451	0.00208	CcSEcCtD
Raltitrexed—Pain—Fluorouracil—skin cancer	0.00045	0.00207	CcSEcCtD
Raltitrexed—Feeling abnormal—Fluorouracil—skin cancer	0.000433	0.00199	CcSEcCtD
Raltitrexed—Diarrhoea—Dactinomycin—skin cancer	0.000432	0.00199	CcSEcCtD
Raltitrexed—Vomiting—Bleomycin—skin cancer	0.00043	0.00198	CcSEcCtD
Raltitrexed—Anaemia—Docetaxel—skin cancer	0.00043	0.00198	CcSEcCtD
Raltitrexed—Rash—Bleomycin—skin cancer	0.000427	0.00196	CcSEcCtD
Raltitrexed—Dermatitis—Bleomycin—skin cancer	0.000426	0.00196	CcSEcCtD
Raltitrexed—Leukopenia—Docetaxel—skin cancer	0.000416	0.00192	CcSEcCtD
Raltitrexed—Body temperature increased—Fluorouracil—skin cancer	0.000416	0.00191	CcSEcCtD
Raltitrexed—Asthenia—Temozolomide—skin cancer	0.000409	0.00188	CcSEcCtD
Raltitrexed—Cough—Docetaxel—skin cancer	0.000406	0.00187	CcSEcCtD
Raltitrexed—Pruritus—Temozolomide—skin cancer	0.000404	0.00186	CcSEcCtD
Raltitrexed—Nausea—Bleomycin—skin cancer	0.000402	0.00185	CcSEcCtD
Raltitrexed—Vomiting—Dactinomycin—skin cancer	0.000401	0.00185	CcSEcCtD
Raltitrexed—Rash—Dactinomycin—skin cancer	0.000398	0.00183	CcSEcCtD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—SHH—skin cancer	0.000397	0.0167	CbGpPWpGaD
Raltitrexed—Arthralgia—Docetaxel—skin cancer	0.000396	0.00182	CcSEcCtD
Raltitrexed—Diarrhoea—Temozolomide—skin cancer	0.00039	0.0018	CcSEcCtD
Raltitrexed—Oedema—Docetaxel—skin cancer	0.00038	0.00175	CcSEcCtD
Raltitrexed—Infection—Docetaxel—skin cancer	0.000377	0.00173	CcSEcCtD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—SMO—skin cancer	0.000377	0.0158	CbGpPWpGaD
Raltitrexed—Nausea—Dactinomycin—skin cancer	0.000375	0.00172	CcSEcCtD
Raltitrexed—Pruritus—Fluorouracil—skin cancer	0.000372	0.00171	CcSEcCtD
Raltitrexed—Thrombocytopenia—Docetaxel—skin cancer	0.000372	0.00171	CcSEcCtD
Raltitrexed—FPGS—Metabolism—PLIN2—skin cancer	0.00037	0.0155	CbGpPWpGaD
Raltitrexed—TYMS—Retinoblastoma (RB) in Cancer—CDK4—skin cancer	0.000363	0.0152	CbGpPWpGaD
Raltitrexed—Vomiting—Temozolomide—skin cancer	0.000363	0.00167	CcSEcCtD
Raltitrexed—Anorexia—Docetaxel—skin cancer	0.000362	0.00166	CcSEcCtD
Raltitrexed—Rash—Temozolomide—skin cancer	0.00036	0.00166	CcSEcCtD
Raltitrexed—Diarrhoea—Fluorouracil—skin cancer	0.00036	0.00166	CcSEcCtD
Raltitrexed—Dermatitis—Temozolomide—skin cancer	0.00036	0.00165	CcSEcCtD
Raltitrexed—Headache—Temozolomide—skin cancer	0.000358	0.00164	CcSEcCtD
Raltitrexed—FPGS—Disease—CSPG4—skin cancer	0.000356	0.0149	CbGpPWpGaD
Raltitrexed—Musculoskeletal discomfort—Docetaxel—skin cancer	0.000346	0.00159	CcSEcCtD
Raltitrexed—Nausea—Temozolomide—skin cancer	0.000339	0.00156	CcSEcCtD
Raltitrexed—TYMS—Fluoropyrimidine Activity—TP53—skin cancer	0.000335	0.0141	CbGpPWpGaD
Raltitrexed—Vomiting—Fluorouracil—skin cancer	0.000334	0.00154	CcSEcCtD
Raltitrexed—Dyspepsia—Docetaxel—skin cancer	0.000334	0.00154	CcSEcCtD
Raltitrexed—Rash—Fluorouracil—skin cancer	0.000332	0.00153	CcSEcCtD
Raltitrexed—Dermatitis—Fluorouracil—skin cancer	0.000331	0.00152	CcSEcCtD
Raltitrexed—Decreased appetite—Docetaxel—skin cancer	0.00033	0.00152	CcSEcCtD
Raltitrexed—Headache—Fluorouracil—skin cancer	0.000329	0.00152	CcSEcCtD
Raltitrexed—Constipation—Docetaxel—skin cancer	0.000325	0.00149	CcSEcCtD
Raltitrexed—Pain—Docetaxel—skin cancer	0.000325	0.00149	CcSEcCtD
Raltitrexed—TYMS—E2F transcription factor network—CDKN2A—skin cancer	0.000319	0.0134	CbGpPWpGaD
Raltitrexed—Feeling abnormal—Docetaxel—skin cancer	0.000313	0.00144	CcSEcCtD
Raltitrexed—Nausea—Fluorouracil—skin cancer	0.000312	0.00144	CcSEcCtD
Raltitrexed—Gastrointestinal pain—Docetaxel—skin cancer	0.00031	0.00143	CcSEcCtD
Raltitrexed—Body temperature increased—Docetaxel—skin cancer	0.0003	0.00138	CcSEcCtD
Raltitrexed—Abdominal pain—Docetaxel—skin cancer	0.0003	0.00138	CcSEcCtD
Raltitrexed—FPGS—Metabolism—CSPG4—skin cancer	0.000298	0.0125	CbGpPWpGaD
Raltitrexed—Asthenia—Docetaxel—skin cancer	0.000272	0.00125	CcSEcCtD
Raltitrexed—Pruritus—Docetaxel—skin cancer	0.000269	0.00124	CcSEcCtD
Raltitrexed—Diarrhoea—Docetaxel—skin cancer	0.00026	0.00119	CcSEcCtD
Raltitrexed—TYMS—Mitotic G1-G1/S phases—CDK4—skin cancer	0.000256	0.0107	CbGpPWpGaD
Raltitrexed—FPGS—Disease—SHH—skin cancer	0.000242	0.0101	CbGpPWpGaD
Raltitrexed—FPGS—Disease—ENO2—skin cancer	0.000242	0.0101	CbGpPWpGaD
Raltitrexed—Vomiting—Docetaxel—skin cancer	0.000241	0.00111	CcSEcCtD
Raltitrexed—Rash—Docetaxel—skin cancer	0.000239	0.0011	CcSEcCtD
Raltitrexed—Dermatitis—Docetaxel—skin cancer	0.000239	0.0011	CcSEcCtD
Raltitrexed—Headache—Docetaxel—skin cancer	0.000238	0.00109	CcSEcCtD
Raltitrexed—Nausea—Docetaxel—skin cancer	0.000225	0.00104	CcSEcCtD
Raltitrexed—FPGS—Metabolism—ENO2—skin cancer	0.000203	0.0085	CbGpPWpGaD
Raltitrexed—FPGS—Disease—FOXO4—skin cancer	0.000197	0.00827	CbGpPWpGaD
Raltitrexed—TYMS—Mitotic G1-G1/S phases—CDKN2A—skin cancer	0.000195	0.00819	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—CDK4—skin cancer	0.000194	0.00812	CbGpPWpGaD
Raltitrexed—TYMS—Circadian rythm related genes—CDK4—skin cancer	0.000186	0.00779	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—MLH1—skin cancer	0.000165	0.00691	CbGpPWpGaD
Raltitrexed—TYMS—Retinoblastoma (RB) in Cancer—TP53—skin cancer	0.000154	0.00648	CbGpPWpGaD
Raltitrexed—FPGS—Disease—ERCC2—skin cancer	0.000141	0.0059	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—PTGS2—skin cancer	0.000138	0.0058	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—PLIN2—skin cancer	0.000135	0.00565	CbGpPWpGaD
Raltitrexed—FPGS—Disease—TERT—skin cancer	0.000132	0.00553	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—ERCC2—skin cancer	0.000118	0.00494	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—CSPG4—skin cancer	0.000109	0.00456	CbGpPWpGaD
Raltitrexed—FPGS—Disease—BRAF—skin cancer	0.000104	0.00438	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle, Mitotic—CDK4—skin cancer	9.37e-05	0.00393	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—TERT—skin cancer	9.36e-05	0.00393	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—KRAS—skin cancer	9.26e-05	0.00389	CbGpPWpGaD
Raltitrexed—FPGS—Disease—PTGS2—skin cancer	8.43e-05	0.00353	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—CDK4—skin cancer	8.38e-05	0.00351	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—TP53—skin cancer	8.23e-05	0.00345	CbGpPWpGaD
Raltitrexed—TYMS—Circadian rythm related genes—TP53—skin cancer	7.9e-05	0.00332	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—ENO2—skin cancer	7.39e-05	0.0031	CbGpPWpGaD
Raltitrexed—TYMS—Circadian rythm related genes—IL6—skin cancer	7.24e-05	0.00303	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle, Mitotic—CDKN2A—skin cancer	7.16e-05	0.003	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—PTGS2—skin cancer	7.06e-05	0.00296	CbGpPWpGaD
Raltitrexed—FPGS—Disease—NRAS—skin cancer	6.56e-05	0.00275	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—CDKN2A—skin cancer	6.4e-05	0.00269	CbGpPWpGaD
Raltitrexed—FPGS—Disease—KRAS—skin cancer	5.64e-05	0.00237	CbGpPWpGaD
Raltitrexed—FPGS—Disease—HRAS—skin cancer	4.8e-05	0.00201	CbGpPWpGaD
Raltitrexed—FPGS—Disease—IL6—skin cancer	4.59e-05	0.00193	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—ERCC2—skin cancer	4.29e-05	0.0018	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—TP53—skin cancer	3.56e-05	0.00149	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—PTGS2—skin cancer	2.57e-05	0.00108	CbGpPWpGaD
